United States· US:76472-7006_594f571e-58a6-48d5-e063-6394a90a198c
Throat Ease
A medicinal product containing atropa belladonna whole; phytolacca americana root; mercurius solubilis, registered in United States by SEVENE USA.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- ATROPA BELLADONNA WHOLE; PHYTOLACCA AMERICANA ROOT; MERCURIUS SOLUBILIS
- Manufacturer
- SEVENE USA
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 1
- ndc1176472-7006-2
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d7a26624-9ff4-405c-85c7-8a8a72c17afd GET /v1/drugs/d7a26624-9ff4-405c-85c7-8a8a72c17afd?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "BUCCAL",
"source": "ndc",
"strength": ".1; .1; .1",
"substance": "ATROPA BELLADONNA WHOLE; PHYTOLACCA AMERICANA ROOT; MERCURIUS SOLUBILIS",
"productndc": "76472-7006",
"dosage_form": "SPRAY",
"dea_schedule": null,
"strength_unit": "mg/100mL; mg/100mL; mg/100mL",
"application_number": null,
"marketing_category": "UNAPPROVED HOMEOPATHIC"
}See everything about atropa belladonna whole; phytolacca americana root; mercurius solubilis.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.